Clinical trial assessing xenon therapy for panic attack patients

Not Applicable

Completed

• Conditions: 1. Panic attack disorder2. Panic attack disorder combined with comorbidity psychiatric conditions; Mental and Behavioural Disorders; Panic attack disorder

• Registration Number: ISRCTN15184285
• Lead Sponsor: obilis Therapeutics

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-14
• Last Update Posted: 24 July 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

1. Diagnosis of panic disorder (F41.0) according to ICD-10
2. Age 18-75
3. Willing to sign informed consent

Exclusion Criteria

1. Known reactions to xenon therapy
2. Organ failure

Study & Design

• Study Type: Interventional
• Study Design: Not specified